trending Market Intelligence /marketintelligence/en/news-insights/trending/iyrncwsy4ke3qv_z3urwlq2 content esgSubNav
In This List

Abeona adds 2 directors, replaces another

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Abeona adds 2 directors, replaces another

Abeona Therapeutics Inc. appointed CEO F. Carsten Thiel to be a director on its board.

Thiel, who was appointed CEO in March, replaces Timothy Miller who will continue to serve as the company's chief scientific officer and president.

The Dallas-based clinical-stage biopharmaceutical company also appointed Stefano Buono and Richard Van Duyne to the board.